dipyridamole has been researched along with Hypoventilation in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Hypoventilation: A reduction in the amount of air entering the pulmonary alveoli.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suga, F | 1 |
| Snow, JB | 1 |
1 other study available for dipyridamole and Hypoventilation
| Article | Year |
|---|---|
Cochlear blood flow in response to vasodilating drugs and some related agents.
Topics: Amyl Nitrite; Angiotensin II; Animals; Asphyxia; Betahistine; Blood Flow Velocity; Blood Pressure; B | 1969 |